Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Chromatin remodeling and leukemia: new therapeutic paradigms.

Redner RL, Wang J, Liu JM.

Blood. 1999 Jul 15;94(2):417-28. Review. No abstract available.

2.

Retinoid receptors in health and disease: co-regulators and the chromatin connection.

Minucci S, Pelicci PG.

Semin Cell Dev Biol. 1999 Apr;10(2):215-25. Review.

PMID:
10441075
3.

Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.

Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C.

Cancer Res. 2001 Jan 1;61(1):2-7.

4.
5.

Arsenicals and inhibitors of histone deacetylase as anticancer therapy.

Warrell RP Jr.

Haematologica. 1999 Jun;84 Suppl EHA-4:75-7. Review. No abstract available.

PMID:
10907475
6.

[Cancer and fusion gene].

Nakata M, Ohki M.

Tanpakushitsu Kakusan Koso. 1997 Sep;42(12):1978-90. Review. Japanese. No abstract available.

PMID:
9301327
7.

Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.

Moldenhauer A, Frank RC, Pinilla-Ibarz J, Holland G, Boccuni P, Scheinberg DA, Salama A, Seeger K, Moore MA, Nimer SD.

J Leukoc Biol. 2004 Sep;76(3):623-33. Epub 2004 Jun 14.

PMID:
15197237
8.

Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.

McNamara S, Wang H, Hanna N, Miller WH Jr.

Mol Cell Biol. 2008 Mar;28(6):2066-77. doi: 10.1128/MCB.01576-07. Epub 2008 Jan 22.

9.

Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.

Nie Z, Yan Z, Chen EH, Sechi S, Ling C, Zhou S, Xue Y, Yang D, Murray D, Kanakubo E, Cleary ML, Wang W.

Mol Cell Biol. 2003 Apr;23(8):2942-52.

10.

[Molecular pathogenesis of leukemias].

Kurokawa M.

Rinsho Ketsueki. 2009 Oct;50(10):1382-8. Review. Japanese. No abstract available.

PMID:
19915346
11.

Histone deacetylases and cancer: causes and therapies.

Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK.

Nat Rev Cancer. 2001 Dec;1(3):194-202. Review.

PMID:
11902574
12.

A distinct epigenetic signature at targets of a leukemia protein.

Rossetti S, Hoogeveen AT, Liang P, Stanciu C, van der Spek P, Sacchi N.

BMC Genomics. 2007 Feb 1;8:38.

13.

[Leukemogenesis by the AML1/EVI-1 chimeric protein].

Mitani K, Hirai H.

Tanpakushitsu Kakusan Koso. 2000 Jan;45(1):33-9. Review. Japanese. No abstract available.

PMID:
10643333
14.

Disruption of a homolog of trithorax by 11q23 translocations: leukemogenic and transcriptional implications.

Waring PM, Cleary ML.

Curr Top Microbiol Immunol. 1997;220:1-23. Review. No abstract available.

PMID:
9103672
15.

AML1 interconnected pathways of leukemogenesis.

Michaud J, Scott HS, Escher R.

Cancer Invest. 2003;21(1):105-36. Review. Erratum in: Cancer Invest. 2003;21(4):659.

PMID:
12643014
16.

AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.

Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD.

Blood. 2000 Dec 1;96(12):3939-47.

18.

Mouse models of acute promyelocytic leukemia.

Pollock JL, Westervelt P, Walter MJ, Lane AA, Ley TJ.

Curr Opin Hematol. 2001 Jul;8(4):206-11. Review. Erratum in: Curr Opin Hematol 2002 Mar;9(2):179.

PMID:
11561157
19.
20.

Transcription factors that regulate growth and differentiation of myeloid cells.

Nagamura-Inoue T, Tamura T, Ozato K.

Int Rev Immunol. 2001 Feb;20(1):83-105. Review.

PMID:
11342299

Supplemental Content

Support Center